Evidence map›Paper›PMID 38273714›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

m

Ane Olazagoitia-Garmendia, Henar Rojas-Márquez, Maialen Sebastian-delaCruz, Aloña Agirre-Lizaso, Anne Ochoa, Luis Manuel Mendoza-Gomez, Maria J Perugorria, Luis Bujanda, Alain Huerta Madrigal, Izortze Santin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Role of MClinical reviews in allergy & immunology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ane Olazagoitia-GarmendiaDepartment of Biochemistry and Molecular Biology, University of the Basque Country UPV/EHU, Leioa, 48940, Spain.
Henar Rojas-MárquezBiobizkaia Health Research Institute, Barakaldo, 48903, Spain.
Maialen Sebastian-delaCruzBiobizkaia Health Research Institute, Barakaldo, 48903, Spain.
Aloña Agirre-LizasoDepartment of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, Donostia-San Sebastian, 20014, Spain.
Anne OchoaDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country UPV/EHU, Leioa, 48940, Spain.
Luis Manuel Mendoza-GomezDepartment of Biochemistry and Molecular Biology, University of the Basque Country UPV/EHU, Leioa, 48940, Spain.
Maria J PerugorriaDepartment of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, Donostia-San Sebastian, 20014, Spain.
Luis BujandaDepartment of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, Donostia-San Sebastian, 20014, Spain.
Alain Huerta MadrigalBiobizkaia Health Research Institute, Barakaldo, 48903, Spain.
Izortze SantinDepartment of Biochemistry and Molecular Biology, University of the Basque Country UPV/EHU, Leioa, 48940, Spain.
Ainara Castellanos-RubioBiobizkaia Health Research Institute, Barakaldo, 48903, Spain.ORCID 0000-0003-3192-9544
University of the Basque Country · ESBiogipuzkoa Health Research Institute · ESIkerbasque · ES

Funding

Departamento de Salud del Gobierno Vasco 2023111056European Foundation for the Study of Diabetes ESPDOC21/56Euskal Herriko Unibertsitatea PIF18/119Eusko Jaurlaritza PRE_2018_2_0039MCIN/AEI PGC2018-097573-A-I00MCIN/AEI PID2019-104475GA-I00
6 · The paper itself

Abstract

Cytokine mediated sustained inflammation increases the risk to develop different complex chronic inflammatory diseases, but the implicated mechanisms remain unclear. Increasing evidence shows that long noncoding RNAs (lncRNAs) play key roles in the pathogenesis of inflammatory disorders, while inflammation associated variants are described to affect their function or essential RNA modifications as N

Indexed as

Inflammatory Bowel DiseasesRNA, Long NoncodingCytokinesHumansInflammationIntestinesCytokinesRNA, Long Noncodingintestinal inflammationlncRNAm6A methylationRNA therapySNP

Identifiers

PMID38273714
PMCPMC10987157
OpenAlexW4391260447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.